What to know, what to ask, and how it is treated — across mania, depression, and staying well.
This guide is not medical advice. It is an educational research summary written in plain language, drawn from published medical literature, major clinical trials, and official guidelines. Every important decision must be made together with the patient’s medical team. Nothing here replaces those conversations. The purpose of this guide is to help patients and families walk into those conversations better prepared. This content does not create a doctor-patient relationship. Trouvera’s guides are produced using AI-assisted research synthesis with human editorial review; they are not written by treating physicians. Laws regarding medical information vary by jurisdiction; consult a local licensed professional for advice specific to your situation.
Standard care first. Bipolar disorder is a lifelong but highly treatable condition. Treatment has three phases — acute mania, bipolar depression, and maintenance — each with specific evidence-based options. Never start, stop, or change a medicine based on this guide alone; work all changes out with your own clinician.
Safety warning. If you are thinking about suicide or cannot stay safe, call or text 988 (Suicide and Crisis Lifeline) any time. Do not stop lithium or other bipolar medicines abruptly — this can trigger relapse.
Content last reviewed: June 2026 · Based on CANMAT/ISBD 2018, APA, NICE CG185, BAP, RANZCP, WFSBP guidelines; FDA labels; UK MHRA/EU EMA valproate measures; key meta-analyses (Cipriani 2011 Lancet, Cipriani 2013 BMJ, Miura 2014 Lancet Psychiatry, Geddes 2004 AJP) and pivotal RCTs. · Always verify with your medical team.
⚡ Quick Start — If You Read Nothing Else
The 10 most important things to know right now.
Bipolar disorder is highly treatable, and most people stabilize. With the right combination of medicine, talk therapy, and steady daily routines, the great majority of people gain good control of their mood episodes and live full lives — working, raising families, and pursuing their goals.
It is a mood disorder with two directions, not just “moodiness.” Bipolar disorder means episodes of unusually high mood or energy (mania or hypomania) at some times, and episodes of depression at others. These are distinct episodes lasting days to weeks — not the hour-to-hour ups and downs everyone has.
Getting the right diagnosis changes everything. Bipolar disorder is often mistaken for ordinary depression for years. Recognizing the “up” side is what leads to the right treatment — and avoids the harm of treating it with an antidepressant alone.
The depression side is actually the bigger burden. Over the long run, most people with bipolar disorder spend far more time depressed than manic. The depressive episodes cause most of the disability — and have their own specific treatments.
Lithium is still one of the best treatments — and uniquely lowers suicide risk. Despite many newer medicines, lithium remains a first-choice long-term mood stabilizer, and it is the one treatment with the strongest evidence for reducing the risk of suicide.
There are now several medicines proven for the depression side. Quetiapine, lurasidone, cariprazine, lumateperone, and an olanzapine–fluoxetine combination are specifically proven for bipolar depression — rather than relying on ordinary antidepressants, which can sometimes make bipolar disorder worse.
Ordinary antidepressants are used cautiously or not at all. On their own they can trigger mania, mixed states, or faster cycling. When used, they are generally given only alongside a mood-stabilizing or anti-mania medicine — and avoided when mixed or rapid-cycling features are present.
Staying well is its own treatment goal. Continuing your maintenance medicine even when you feel completely well — combined with education about the illness and a steady sleep–wake routine — dramatically reduces relapses. Long-acting injectable options can help when daily pills are hard.
Treatment is made safer with the right monitoring. Knowing the warning signs of lithium toxicity, the slow build-up lamotrigine needs to avoid a serious rash, and the weight/blood-sugar checks needed with antipsychotics makes long-term treatment both effective and safe.
You are not alone, and there is a number to call. If you are thinking about suicide or cannot stay safe, call or text 988 (the Suicide and Crisis Lifeline) any time. Bipolar disorder carries real risk, but with a plan it becomes a condition that can be managed for the long term.
▼ Collapse
Start Here: Understanding Bipolar Disorder
Bipolar disorder is a lifelong, episodic mood disorder. That word “episodic” is the key: the illness comes in episodes — periods of weeks or months when mood, energy, sleep, and thinking shift well outside a person’s normal range — with stretches of stability in between. At some times the shift is upward (mania or a milder form called hypomania); at other times it is downward (depression). For most people, the depressive episodes are more frequent and last longer than the high periods.
This is different from everyday moodiness. Everyone feels up some days and down others, sometimes within the same hour. Bipolar episodes are sustained changes in functioning — how much you sleep, how fast your thoughts and speech move, how much you can get done, how you handle money and risk — that other people around you usually notice, and that interfere with work, relationships, or safety.
One sentence to remember. Bipolar disorder is a treatable medical condition of the brain’s mood-regulation system — not a character flaw, a lack of willpower, or something a person chooses. With treatment, the great majority of people do well.
Bipolar disorder affects roughly 1–2% of people across countries and cultures — the same broad range whether you are in Salt Lake City, São Paulo, Seoul, or Stockholm. It usually first appears in the late teens or twenties, and it is one of the leading medical causes of disability worldwide. None of that means a hard life is inevitable. It means the condition is common, well-studied, and has a large and growing toolkit of treatments.
Why this guide is built in stages
Treatment of bipolar disorder has three distinct phases, and the medicines that help in one phase are not always the same ones that help in another. This guide follows that structure:
Understanding the diagnosis and types — what bipolar I, bipolar II, and cyclothymia are, and why getting the label right matters.
Treatment: mania, depression, and staying well — the three phases and the proven options for each.
Living well and preventing relapse — talk therapy, routines, early-warning signs, and safety planning.
Pregnancy, youth, and special situations — careful, individualized planning.
Support and resources — where to get help, including in Utah and nationally.
Important safety note. This guide is educational and does not replace care from your own clinicians. It does not tell you to start, stop, or change any medicine. Bipolar medicines should never be started or stopped suddenly on your own — stopping lithium abruptly, in particular, can trigger a relapse. Always work changes out with your prescriber.
What causes bipolar disorder?
There is no single cause. Bipolar disorder runs in families — genetics account for a substantial part of the risk — but no one gene “causes” it; many genes each add a small amount of vulnerability. On top of that genetic background, life events, sleep disruption, substance use, and stress can act as triggers that set off episodes in someone who is already vulnerable. This is why two things are true at once: bipolar disorder is a real, biologically based brain condition and the things you do (sleep, routines, avoiding heavy alcohol use, managing stress) genuinely affect how often episodes happen. You did not cause your illness, and your relatives did not cause it in you; but you can do a great deal to influence its course.
Having a parent or sibling with bipolar disorder raises a person’s risk compared with the general population, which is one reason family history is such an important part of the diagnostic conversation. It is also why, if you have bipolar disorder, it can be worth being alert to early signs in close relatives — not to worry, but so that help can come early if it is ever needed.
What to expect over time
Bipolar disorder is usually a long-term, relapsing condition: episodes tend to come and go across a lifetime, often with long well periods in between, especially once treatment is working. A few patterns are worth knowing:
The depressive side usually predominates. Over years, most people spend far more time in depressive or low-grade depressive states than in highs. This is why so much of this guide focuses on the depression side and on prevention.
Episodes can shorten the gaps over time if untreated. One reason to treat early and consistently is that well-managed illness tends to stay more stable, while repeated untreated episodes can make the pattern harder to control.
Most people stabilize with the right plan. “Stable” doesn’t mean never having a tough day; it means episodes become less frequent, less severe, and more manageable, so you can build and keep the life you want.
Realistic and hopeful. Bipolar disorder is serious — it deserves real treatment and ongoing attention. It is also one of the most treatable conditions in psychiatry. People with bipolar disorder lead full lives in every field — working, parenting, creating, leading. The goal of treatment is not just to end an episode but to give you back the steady ground to live the life you choose.
You get far more out of appointments when you bring information. Useful things to track and bring:
A simple mood + sleep log: a daily note of overall mood (a 1–10 scale is fine), hours slept, and anything notable. Patterns — like sleep dropping before a high — often show up here first.
Episode history: roughly when past highs and lows happened, how long they lasted, and what was going on (stress, travel, new medicines, substances).
Current medicines and doses, including anything over-the-counter, supplements, and how consistently you’ve been taking them (honestly — this is information, not a test).
Side effects you’ve noticed, and questions you want answered.
Lab dates (for example, your last lithium level, kidney, and thyroid tests).
If it helps, bring a trusted person who may have seen things you didn’t. Write your top two or three questions at the top of the page so they don’t get lost.
Mood stabilizers: lithium, valproate (divalproex), lamotrigine, and carbamazepine. These are the backbone of long-term treatment.
Second-generation (atypical) antipsychotics: quetiapine, aripiprazole, risperidone, olanzapine, asenapine, cariprazine, lurasidone, lumateperone, ziprasidone, and paliperidone. Despite the name, in bipolar disorder these are used as mood medicines — for mania, for depression (several are specifically proven for it), and for prevention. You do not have to have psychosis to be prescribed one.
Antidepressants: the familiar SSRIs and others. In bipolar disorder these have a limited and cautious role — explained in the depression section.
Short-term helpers: medicines for sleep or agitation, used briefly during an acute episode.
What exactly is bipolar disorder, and how is it different from the ordinary mood swings everyone has, or from depression alone?
What makes you think this is bipolar disorder rather than something else?
Which type do you think I have, and what does that mean for my treatment?
What are the three phases of treatment, and which phase am I in right now?
What is the goal of treatment for me — getting through this episode, or staying well long-term, or both?
Where can I learn more from sources you trust?
Understanding the Diagnosis & Types
Bipolar disorder is not one single thing. It is a spectrum, and your specific diagnosis shapes which treatments are most likely to help. The differences come down to how high the high episodes go and whether full depression has occurred.
The building blocks: what an “episode” looks like
Clinicians describe four kinds of episodes. Recognizing them in yourself — especially the high ones, which can feel good and are easy to overlook — is the heart of getting the diagnosis right.
A distinct period (at least about a week, or any length if hospitalization is needed) of abnormally elevated, expansive, or irritable mood plus clearly increased energy or activity, with several of: less need for sleep (feeling rested after a few hours), racing thoughts, rapid or pressured speech, inflated self-esteem or grandiosity, distractibility, and increased risky or goal-directed activity (spending sprees, sexual indiscretions, ambitious projects, reckless driving). Mania causes serious problems — in work, relationships, finances, or the law — or includes psychosis (losing touch with reality), or requires hospital care. At least one manic episode defines bipolar I disorder.
The same kind of change, but shorter (at least about 4 days) and less severe — noticeable to others as a clear departure from your usual self, but not causing major impairment, psychosis, or a need for hospital care. Hypomania can even feel productive and pleasant, which is exactly why it is so easily missed. People rarely seek help during a hypomanic period; they seek help when they crash into depression afterward. Hypomania (plus a past major depression) defines bipolar II disorder.
At least two weeks of low mood and/or loss of interest or pleasure, with changes such as sleeping too much or too little, appetite or weight change, fatigue, trouble concentrating, feelings of worthlessness or guilt, slowed or agitated movement, and thoughts of death or suicide. Bipolar depression can look just like ordinary (unipolar) depression from the outside — which is why the history of any past high period is so important.
Sometimes high and low symptoms occur together — for example, deep depression with racing thoughts, agitation, and irritability, or mania with sudden tearfulness and hopelessness. Mixed states feel awful, are linked to higher suicide risk, and change treatment: in particular, antidepressants are generally avoided when mixed features are present.
The three main types
Type
What defines it
What it tends to look like
Bipolar I
At least one full manic episode (depression is common but not required for the diagnosis)
The “classic” form; manias can be severe and may include psychosis or need hospital care
Bipolar II
At least one hypomanic episode plus at least one major depressive episode — and never a full mania
Often dominated by long, hard-to-treat depressions; frequently misdiagnosed as ordinary depression
Cyclothymic disorder
Two or more years of many periods of hypomanic-type and depressive-type symptoms that don’t meet full episode criteria
Chronic, fluctuating “low-grade” instability; can later develop into bipolar I or II
Doctors also describe specifiers that fine-tune the picture: rapid cycling (four or more episodes in a year), with psychotic features, with anxious distress, with seasonal pattern, and peripartum onset (around childbirth). These matter because they steer treatment — for example, rapid cycling makes clinicians especially wary of antidepressants.
Why bipolar II is not “bipolar lite.” Because the highs are milder, bipolar II is sometimes treated as less serious. But its depressions are often longer and more disabling than bipolar I depressions, and the suicide risk is real. Bipolar II deserves the same careful, long-term treatment.
What episodes can feel like from the inside
Clinical lists describe symptoms from the outside. From the inside, episodes can be confusing — which is part of why they’re hard to recognize in yourself.
Hypomania often doesn’t feel like illness at all. It can feel like your best self — energized, creative, confident, socially at ease, needing little sleep, getting a lot done. That’s exactly why people rarely seek help during it and may resist the idea that it’s part of an illness. The trouble usually shows up later, in the crash, in damaged relationships, or in decisions made too fast.
Mania can start in that same appealing place and then accelerate past control — thoughts racing too fast to finish, irritability when others can’t keep up, spending or risks that seem reasonable in the moment, and sometimes a loss of touch with reality. Insight often disappears during mania; the person genuinely cannot see what others see. This is a symptom, not stubbornness.
Bipolar depression frequently brings heavy fatigue, sleeping too much, and a leaden, slowed-down feeling, alongside the hopelessness and loss of interest common to all depression. It can be profoundly disabling and is the part most people most want relief from.
Mixed states are often the hardest to bear — the energy and racing thoughts of a high combined with the despair of a low. This combination is dangerous and deserves prompt help.
Why bipolar disorder is so often mistaken for depression
People almost always seek help when they are depressed, not when they are high — the high periods can feel good, or are remembered as “just a really productive stretch.” So the first doctor often sees only depression and reasonably diagnoses depression. On average, there is a long delay — frequently several years and several wrong diagnoses — before bipolar disorder is correctly identified. The cost of that delay is not just lost time: treating bipolar depression with an antidepressant alone can trigger mania, mixed states, or faster cycling, and can leave the underlying instability untreated.
The single most important question. Anyone with depression should be asked: have you ever had a period of unusually elevated, expansive, or irritable mood with decreased need for sleep, racing thoughts, fast speech, increased risky or goal-directed activity, or grandiosity? Even one true manic or hypomanic episode points to bipolar disorder — and points toward mood-stabilizer-based treatment instead of an antidepressant alone.
How the diagnosis is made
There is no blood test or brain scan that diagnoses bipolar disorder. The diagnosis is clinical — built from your history, your symptoms over time, and, very helpfully, information from people who know you well and may have seen highs you didn’t recognize in yourself. A careful clinician will ask about the whole arc of your life, not just how you feel today, and will rule out other causes (thyroid problems, substances, medications, other psychiatric conditions).
Screening questionnaires like the Mood Disorder Questionnaire (MDQ) can help start the conversation, but they are screens, not diagnoses — they miss some people and over-flag others. A positive screen means “worth a careful look,” not “you have bipolar disorder.”
Because there is no test for bipolar disorder, the quality of the evaluation matters enormously — and you can do things to make it more complete and accurate.
A thorough assessment usually includes:
The whole arc of your life, not just today. A good clinician asks about your moods, sleep, energy, and behavior across years — looking specifically for any past period of unusually elevated, expansive, or irritable mood with reduced need for sleep. This is the part most often skipped in a rushed visit, and it is the part that distinguishes bipolar disorder from depression.
Information from someone who knows you. Highs are easy to miss from the inside. A partner, parent, or close friend may have seen a stretch of barely sleeping, fast talking, big plans, or risky spending that you experienced as just “a great few weeks.” Bringing that person, or their written notes, can change the diagnosis.
Ruling out other causes. Thyroid problems, substances, certain medications, and other conditions can mimic mood episodes and are checked with history and simple tests.
A look at past treatment. Depression that never responded to antidepressants — or that flipped into agitation, sleeplessness, or a “high” when you took one — is an important clue.
How to advocate for a complete evaluation: If you’ve been treated for depression that hasn’t improved, it’s reasonable to ask directly, “Could this be bipolar disorder? Have we looked carefully at whether I’ve ever had a high period?” You can offer to bring a family member, write down your episode history in advance, and mention any family history of bipolar disorder. If you feel your highs are being overlooked, it is fair to ask for a referral to a psychiatrist with mood-disorder expertise. Getting the diagnosis right is the single biggest step toward effective treatment — it is worth pushing for.
Unipolar (ordinary) depression — the most common mix-up; the difference is the history of highs.
Borderline personality disorder — mood shifts here are usually faster (hours), tied to relationships, and different in quality; the two can also co-occur.
ADHD — shares distractibility and restlessness, but is continuous from childhood rather than episodic; the two can co-occur.
Substance-induced mood changes — stimulants, alcohol, and some medications can mimic highs or lows.
Thyroid disease and other medical causes — checked with simple tests.
Which type do I have — bipolar I, bipolar II, or cyclothymia — and why does that matter for my treatment?
What does a manic, hypomanic, mixed, or depressive episode look like specifically for me?
Why is bipolar disorder often mistaken for depression, and how confident are you in my diagnosis?
Do I have any specifiers — rapid cycling, mixed features, psychotic features, seasonal pattern — and how do they change the plan?
Could anything else explain my symptoms (thyroid, substances, ADHD, a personality disorder), and have those been checked?
Would it help for my partner or a family member to come to an appointment to describe what they’ve seen?
If I’ve been on an antidepressant alone, should that change now?
Caregiver note. You may have seen highs the person didn’t notice or remember — a stretch of barely sleeping, big plans, fast talking, irritability, or risky spending. Writing these down (roughly when, how long, what happened) and sharing them with the clinician can be the single most useful thing you do. Lack of insight during a high is part of the illness, not stubbornness.
Treatment: Mania, Depression & Staying Well
Treatment comes in three phases, each with its own goal and its own best-proven medicines. The same drug is not equally good at all three jobs — which is why your plan may use different medicines at different times, or one medicine that covers more than one phase.
Phase
Goal
Commonly used, evidence-based options
Acute mania / mixed
Calm the episode quickly and safely
Lithium or valproate, and/or a second-generation antipsychotic; combination for severe episodes; stop antidepressants; short-term help for sleep/agitation
Usually continue what got you well — often lithium, lamotrigine, quetiapine, or aripiprazole; long-acting injectables for adherence
Phase 1 — Treating acute mania and mixed states
A manic episode is a medical priority because of the risk to safety, relationships, finances, and health. The usual approach is a mood stabilizer (lithium or valproate) or a second-generation antipsychotic on its own for milder mania, and a combination (lithium or valproate plus an antipsychotic) for severe mania. Any antidepressant is generally stopped. Short-term medicines may be used for sleep and agitation, and a calm, low-stimulation environment helps. For severe, dangerous, or treatment-resistant mania — or when a fast response is essential — hospital care or, occasionally, electroconvulsive therapy (ECT) may be needed.
What the evidence shows. In a large comparison of all the anti-mania drugs, the antipsychotics (especially risperidone, olanzapine, and haloperidol) and lithium were among the most effective; some older anticonvulsants used for other purposes were not effective for mania. The right choice for you depends on severity, past response, other health conditions, side-effect profile, and whether pregnancy is a consideration.
A newer option for mania. In February 2026 the United States approved a new once-daily pill called milsaperidone (brand name Bysanti) for treating manic or mixed episodes of bipolar I in adults. It is a type of antipsychotic that the body converts into another well-known medicine (iloperidone). It adds another choice for the acute phase; because it is new, your team will weigh it against more established options, and longer-term experience with it is still building. As with any new medicine, ask about benefits, side effects, and cost.
Phase 2 — Treating bipolar depression
This is the part that matters most over a lifetime, because the depressive pole dominates the long-term course. The good news is that bipolar depression now has specific proven treatments — you do not have to rely on ordinary antidepressants.
Medicine
Notes
Quetiapine
Proven for bipolar depression; also used for mania and maintenance; can be sedating and cause weight gain
Lurasidone (Latuda)
Proven for bipolar I depression, alone or added to lithium/valproate; relatively weight-neutral; take with food
Cariprazine (Vraylar)
Proven across bipolar I depression, mania, and mixed episodes — one medicine covering the spectrum
Lumateperone (Caplyta)
Proven for bipolar I and II depression, alone or added to lithium/valproate; favorable weight/metabolic profile; no dose titration needed
Olanzapine–fluoxetine combination
An antipsychotic paired with an antidepressant in one product; effective but more weight/metabolic effect
Lithium
Helps depression somewhat and is a backbone for prevention and suicide-risk reduction
Lamotrigine
Best at preventing future depressions; modest for treating an acute depressive episode; must be titrated slowly
Why ordinary antidepressants are used cautiously. In bipolar disorder, an antidepressant given by itself can flip mood into mania or a mixed state, or speed up cycling. When antidepressants are used at all, they are generally given only alongside a mood-stabilizing or anti-mania medicine, and are usually avoided when mixed features or rapid cycling are present. This is one of the biggest practical reasons the correct diagnosis matters.
Medicines for bipolar disorder rarely work instantly, and that is normal — not a sign of failure.
Mania: antipsychotics often begin calming symptoms within days; lithium works a little more slowly. Restoring sleep is itself part of the treatment.
Depression: the proven medicines for bipolar depression usually take a few weeks to show their full effect. Give a fair trial at an adequate dose before judging it, unless side effects force a change.
Lamotrigine is deliberately increased slowly over several weeks to avoid a serious rash, so it is not a fast fix for an acute low — its real strength is preventing future depressions.
Lithium is dosed to a blood level, so the first weeks involve some checking and fine-tuning to find your range.
Finding the right fit can take more than one try. Many people need an adjustment or a combination before they land on a plan that works and is tolerable. That is ordinary, not a setback.
Tell your clinician about side effects rather than stopping on your own — most are manageable, and stopping suddenly (especially lithium) is itself a common trigger for relapse.
Phase 3 — Maintenance: staying well
Maintenance is where lives are rebuilt. The single most reliable predictor of staying well is continuing effective medicine — usually the agent that brought you back to stability — even after you feel completely normal. Stopping early, especially stopping abruptly, is the most common path back into episodes.
Common maintenance choices include lithium (the most studied, with the unique anti-suicide signal), lamotrigine (especially to prevent the depressive pole), quetiapine, and aripiprazole, among others. Which agent “best” prevents the next episode depends partly on your predominant polarity — whether you tend to relapse into depression or into mania.
Long-acting injectables. If taking a daily pill reliably is hard — and it is hard for many people, for many understandable reasons — some antipsychotics (for example, aripiprazole) come as a long-acting injection given every few weeks. This can make staying well far easier and is worth asking about without embarrassment. A newer once-monthly option, a long-acting form of risperidone (brand name UZEDY), was approved in the United States in October 2025 specifically to help maintain stability in bipolar I — on its own or alongside lithium or valproate. Ask your team whether a once-monthly injection might fit your life.
These medicines differ a lot from one another in side effects, even though they share a category. Knowing the differences helps you and your prescriber match one to your priorities.
Quetiapine — works across mania, depression, and maintenance; often sedating (sometimes used to help sleep), with meaningful weight/metabolic effects.
Lurasidone — a go-to for bipolar depression; relatively weight-neutral; must be taken with food (at least a light meal) to be absorbed; can cause restlessness (akathisia).
Cariprazine — covers depression, mania, and mixed episodes; relatively weight-favorable; can cause akathisia and nausea; long-acting in the body, so effects build and fade slowly.
Lumateperone — proven for both bipolar I and II depression; notably favorable for weight and metabolism; taken once daily with no need to slowly increase the dose; can cause drowsiness and dry mouth.
Aripiprazole — weight-favorable; used for mania and maintenance (especially preventing highs); available as a long-acting injection; akathisia is the main nuisance.
Olanzapine — very effective but among the highest for weight gain and metabolic change, so often not a first long-term choice.
Risperidone — effective for mania; can raise the hormone prolactin (causing breast tenderness, milk production, or cycle changes); available as a long-acting injection.
Asenapine — a dissolve-under-the-tongue tablet; can numb the mouth briefly.
Ziprasidone — weight-favorable; needs to be taken with food; can affect heart rhythm (QT), so sometimes an ECG is checked.
None of this is a recommendation for or against any one medicine — it’s a map so you can ask informed questions about the trade-offs that matter most to you (sleep, weight, restlessness, convenience, an injectable option).
Side effects are real, but most are manageable — and managing them well is part of staying on treatment. A few general points:
Weight and metabolism (antipsychotics): tracked with weight, blood sugar, and cholesterol checks; managed with diet, activity, choosing a more weight-neutral agent, and sometimes additional medicines. Don’t suffer in silence — raise it.
Restlessness/akathisia: an inner urge to move; tell your prescriber, as it often responds to a dose change or added medicine.
Tremor, increased thirst/urination, thyroid changes (lithium): monitored with labs; often manageable with dose timing or adjustment.
Drowsiness: sometimes eases over time, or the dose can be shifted to bedtime.
Sexual side effects: common with several medicines and worth raising; there are often options.
The goal is the lowest effective treatment that keeps you well with side effects you can live with — finding that often takes some adjustment, which is normal.
One of the most demoralizing myths about bipolar treatment is that the first medicine should just work, and that needing to adjust or change it means something has gone wrong. The reality is the opposite: finding the right regimen is usually a process of informed trial and adjustment, and that is ordinary, not failure.
Here is what to expect, so the process feels less discouraging:
Medicines are matched to you, not just to the diagnosis. Your prescriber weighs which phase you’re in, whether you tend toward depression or mania, other health conditions, whether pregnancy is a consideration, and which side effects you most want to avoid (weight, sedation, restlessness). Two people with the same diagnosis can reasonably be on very different medicines.
Adequate trials take time. The proven medicines for bipolar depression usually need a few weeks at a proper dose to show their full effect; lamotrigine is deliberately increased slowly over weeks to avoid a rash; lithium is fine-tuned to a blood level. Judging a medicine too early — before it has had a fair trial — is a common reason people conclude “nothing works.”
Adjustment is normal. Many people need a dose change, a switch, or a combination before landing on a plan that is both effective and tolerable. Each step is information, narrowing toward the right fit.
Side effects are a conversation, not a reason to quit silently. Most side effects are manageable with a dose change, a timing change, or a different agent. Stopping abruptly on your own — especially lithium — can trigger a relapse, so raise problems with your prescriber rather than stopping.
“Tolerable and sustainable” beats “perfect on paper.” The best regimen is the one you can actually live with and keep taking for the long term, because consistency is what prevents relapse.
If you feel like a “difficult case” because it took a few tries, reframe it: you and your prescriber are doing exactly what good treatment requires — personalizing, observing, and adjusting until you find what keeps you well.
A very common worry — and a real reason some people stop their medicine — is the fear that treatment will flatten their personality, dull their creativity, or take away the energy and drive they associate with their best self. This concern deserves an honest, respectful answer rather than dismissal.
The fear is understandable, especially about hypomania. The mild high can feel productive, creative, and confident, so the idea of “losing” it is a genuine loss to grieve. Naming that openly — rather than pretending the highs were all bad — is part of coming to terms with the illness.
But untreated bipolar disorder is far more destructive to creativity and achievement than treatment is. Episodes — especially the long depressions and the crashes after highs — derail careers, relationships, and creative work for months at a time. Stability is what lets people actually finish projects, sustain careers, and build a life. Many accomplished people in every field do their best work because they are well-treated, not despite it.
If a medicine genuinely makes you feel flat, foggy, or “not yourself,” that is a problem to solve, not something to endure. Over-sedation, cognitive dulling, or emotional blunting often respond to a dose change, a timing change, or a switch to a different medicine. Tell your prescriber specifically what you’re experiencing — the goal is a regimen that keeps you well and feels like you.
Don’t test the question by stopping suddenly. Quitting medicine to “see if you still need it” risks a relapse (and abrupt lithium stops can trigger one). If you want to adjust, do it as a planned conversation with your prescriber.
The aim of good treatment is not to mute you — it is to give you steady ground so the real you, with your talents and ambitions intact, can show up consistently rather than in unpredictable bursts.
Some bipolar medicines need regular blood tests. This is not bureaucracy — it is what makes long-term treatment both effective and safe, and understanding it helps you stay on top of your own care.
Lithium has a “narrow window”: the level that works and the level that is too high are not far apart. Blood tests check that your level is in range and that your kidneys, thyroid, and calcium stay healthy over the years. Expect more frequent checks when starting or changing the dose, then roughly every few months once you’re stable. Know the signs that lithium may be too high (persistent vomiting or diarrhea, a coarse tremor, unsteadiness, slurred speech, confusion) and that dehydration, certain painkillers (ibuprofen and other NSAIDs), and some blood-pressure pills can push the level up.
Valproate and carbamazepine need checks of liver function and blood counts, especially early on, and carbamazepine can lower sodium and interact with many other medicines (including some birth control).
Antipsychotics call for tracking weight, blood sugar, and cholesterol, because some can raise these over time. Catching changes early lets you and your prescriber act — with diet and activity, a switch to a more weight-neutral medicine, or added treatment — before they become a problem.
Keep your own simple record. Noting your last lithium level and lab dates means nothing slips through the cracks if you change clinics or see a new prescriber.
Think of monitoring as the safety system that lets you benefit from these medicines for the long haul. It is a sign of good care, not a burden.
Red flags — when to seek urgent or emergency help. Call your clinician urgently, or seek emergency care, for: thoughts of suicide or a plan; inability to stay safe; psychosis (hearing/seeing things others don’t, or strong false beliefs); severe agitation; signs of lithium toxicity (persistent vomiting/diarrhea, coarse tremor, unsteadiness, slurred speech, confusion); a spreading rash, blistering, or mouth/eye sores while on lamotrigine (possible serious reaction); or high fever with muscle stiffness and confusion on an antipsychotic (a rare but dangerous reaction). When in doubt, call — or call/text 988 for a mental-health crisis.
Caregiver note — supporting medication and monitoring. Two practical roles make a real difference. First, help keep treatment consistent — a shared pill organizer, phone reminders, or a simple calendar — without turning it into surveillance; collaboration works better than policing. Second, help track lab appointments, especially lithium levels and kidney and thyroid tests, and watch for lithium-toxicity warning signs (vomiting, diarrhea, coarse tremor, confusion, unsteadiness) and dehydration triggers like illness, hot weather, or heavy exercise. If you notice toxicity signs, treat it as urgent and contact the clinician.
Lithium is a naturally occurring element used as a medicine for over half a century. It helps both poles to a degree, is a foundation for long-term prevention, and uniquely lowers suicide risk. Its level in the blood must stay in a narrow window, so it needs regular blood tests (level, kidneys, thyroid, and calcium). It is best thought of as the all-rounder and the long-term anchor.
Valproate (divalproex) works well and quickly for mania. Its major limitation: it can seriously harm a developing baby, so it is generally avoided in people who could become pregnant. It also requires monitoring for liver problems, low platelets, and other effects.
Lamotrigine is the depression-prevention specialist — very good at delaying the next depressive episode, less useful for acute mania. It must be started at a low dose and increased slowly over weeks to avoid a rare but serious rash.
Carbamazepine is another option, effective for mania but with many drug interactions and its own monitoring needs.
Lithium has a narrow therapeutic window: the dose that works and the dose that is too much are not far apart. Blood tests check that the level is in range and that your kidneys, thyroid, and calcium stay healthy over time. Things that raise lithium to dangerous levels include dehydration (vomiting, diarrhea, heavy sweating, hot weather), and certain medicines — common painkillers (NSAIDs like ibuprofen), some blood-pressure medicines (ACE inhibitors/ARBs), and water pills (thiazide diuretics).
Warning signs of lithium toxicity — treat as urgent: persistent vomiting or diarrhea, a new coarse (large) tremor, unsteadiness or trouble walking, slurred speech, confusion or drowsiness, muscle twitching. If these appear, contact your clinician or seek urgent care; hold further doses until you get advice, and stay hydrated unless told otherwise.
Second-generation antipsychotics are central to bipolar treatment, but they can cause weight gain and metabolic changes (higher blood sugar and cholesterol), so your weight, blood sugar, and cholesterol should be checked before starting and periodically after. Some can cause restlessness (akathisia), stiffness or tremor, or — rarely, with long use — involuntary movements (tardive dyskinesia). They differ a lot from each other: lurasidone and lumateperone tend to be more weight-neutral; olanzapine and quetiapine carry more metabolic risk. There is a boxed warning about increased death in older adults with dementia-related psychosis — a different situation from bipolar disorder, but worth knowing about.
Which phase am I being treated for right now — mania, depression, or maintenance?
How do mood stabilizers like lithium, valproate, and lamotrigine work, and what is each best for in my case?
Which medicine are you recommending for the depression side, and why that one?
Why are we avoiding (or being careful with) ordinary antidepressants for me?
If I take lithium, how often will I need blood tests, and what toxicity signs should I watch for?
What metabolic monitoring do I need with an antipsychotic, and which agents are most weight-neutral?
If lamotrigine is suggested, what is the titration schedule and what rash should alarm me?
Would a long-acting injectable make sense for me?
How long should I expect to stay on maintenance medicine?
Living Well & Preventing Relapse
Medicine is necessary but not sufficient. The people who do best combine the right medicine with skills, routines, and support that make the medicine work better and catch trouble early. Think of this as the other half of treatment.
Talk therapy and psychoeducation
Several structured therapies are proven to reduce relapses when added to medicine — they are not a substitute for medicine, but a powerful partner to it.
Psychoeducation — structured learning about the illness, your personal warning signs, and your plan. Simple, well-supported, and often delivered in groups.
Cognitive-behavioral therapy (CBT) — tools for managing depressive thinking, stress, and the behaviors that destabilize mood.
Family-focused therapy (FFT) — brings family or partners into education and communication; especially helpful for young people and for reducing household conflict that can trigger episodes.
Interpersonal and social rhythm therapy (IPSRT) — focuses on stabilizing daily rhythms (sleep, meals, activity) and managing relationship stresses, on the principle that disrupted rhythms can set off episodes.
Sleep is medicine. A regular sleep–wake schedule is one of the most powerful stabilizers there is. Too little sleep can trigger mania; disrupted sleep often signals an episode starting. Protecting consistent sleep — same bedtime and wake time, even on weekends — is a daily treatment, not just self-care.
Of all the things you can do yourself, protecting a steady daily rhythm — especially sleep — has some of the strongest evidence behind it. Bipolar disorder is, in part, a condition of the body’s internal clock, and the timing of sleep, meals, light, and activity genuinely influences mood stability. This is the idea behind a proven therapy called interpersonal and social rhythm therapy (IPSRT).
What this looks like in practice:
Anchor your sleep. Aim for the same bedtime and wake time every day, including weekends. A consistent wake time, in particular, helps set the whole rhythm. A sudden drop in how much sleep you need — feeling rested on far less — is one of the most reliable early warning signs of a high, so changes in sleep are worth noticing immediately.
Be careful with anything that disrupts the clock. Overnight travel across time zones, night-shift work, and all-nighters are genuine risks, not just inconveniences. If they’re unavoidable, plan ahead with your clinician about how to protect yourself around them.
Use light deliberately. Bright light in the morning and a dimmer, screen-light environment in the evening reinforce a healthy rhythm. Any structured light therapy for bipolar depression should be done with your clinician, because, like other antidepressant treatments, it can occasionally push mood upward.
Keep meals and activity regular too. Predictable daily structure — not rigidity, just rhythm — supports a stable mood.
Treat sleep problems seriously. If you snore heavily or are exhausted despite enough hours, ask about sleep apnea; poor-quality sleep destabilizes mood even when the hours look fine.
None of this replaces medicine, but it makes medicine work better and gives you a daily, concrete way to protect your stability.
Staying well long-term is an active skill, not just a matter of luck or medication. People who do best tend to assemble a small, personal “toolkit” — built while they are well — that they and their support people can reach for. Yours might include:
Your early-warning sign list. The specific, personal signals that an episode may be starting — for a high, often a drop in sleep, racing thoughts, new big plans, or irritability; for a low, withdrawing, losing interest, or sleeping more. Writing these down with someone who knows you well makes them easier to catch.
An “if-then” action plan. Decide in advance what happens when a warning sign appears — for example, “If I sleep poorly two nights in a row, I call my clinician,” or “If I start spending impulsively, my partner holds the credit card and we review the plan.” Acting early, when symptoms are mild, is far easier and more effective than acting in a full episode.
A simple daily tracker. A quick note of mood, hours slept, and medicine taken makes slow changes visible before they become episodes.
Your steady habits. Consistent sleep and wake times, limited alcohol, regular activity, and stress management — the daily rhythm that holds everything together.
A written crisis plan. Names, numbers (including 988), your medicines, what helps, and what you want others to do during an episode — shared with the people you trust.
Your support team. Clinician, therapist, a trusted person or two, and ideally a peer-support connection (such as DBSA), so you’re not relying on any single source of help.
The point of the toolkit is to turn good intentions into a concrete plan that works even on hard days — and to shift from reacting to crises toward catching changes early, when small adjustments do the most good.
Daily routines and lifestyle
Keep rhythms steady: consistent sleep, meals, light exposure, and activity. Be especially careful with travel across time zones and with night-shift work.
Limit alcohol and recreational drugs: they destabilize mood, interact with medicines, and raise risk — substance use is one of the most common reasons treatment stops working.
Manage stress: major stress and conflict are common triggers; therapy and planning help.
Track your mood: a simple daily mood/sleep log (paper or an app) makes patterns and early warning signs visible to you and your clinician.
Here is a fact that is sobering but also hopeful: on average, people with bipolar disorder have a shortened life expectancy, and most of that gap comes not from the mood disorder itself but from preventable physical illness — especially heart disease. Hopeful, because these risks are largely modifiable, and looking after your physical health is genuinely part of treating bipolar disorder, not a separate chore.
Keep up with the basic checks. Weight, blood pressure, blood sugar, and cholesterol — especially if you take an antipsychotic, some of which can raise these. Catching changes early lets you and your clinician act before they become problems.
Move regularly. Exercise improves mood, sleep, and heart health, and helps counter medication-related weight gain. It doesn’t have to be intense — regular walking counts. (A note: a sudden surge in exercise and energy can also be an early sign of a high, so steady, planned activity is better than sudden bursts.)
Eat in a way you can sustain. A heart-healthy pattern (plenty of vegetables, whole grains, lean protein; limited ultra-processed food and sugary drinks) supports both physical health and steadier energy. Crash diets and big routine disruptions are best avoided.
Don’t smoke — and get help to quit if you do. Smoking is common in bipolar disorder and is a major driver of the heart-disease risk; quitting is one of the highest-impact things you can do, and support makes it far more achievable.
Treat sleep apnea and other conditions. Loud snoring or daytime exhaustion despite enough hours is worth checking — poor-quality sleep destabilizes mood as well as harming the heart.
Ask your team to coordinate. Ideally your mental and physical health are managed together, not in separate silos. It’s reasonable to ask your psychiatrist and primary care doctor to communicate.
None of this competes with your mood treatment — it reinforces it. Protecting your body protects your brain, your energy, and the long life you’re building.
Substance use is one of the most common — and most fixable — reasons bipolar treatment seems to stop working. This isn’t about judgment; it’s about a few facts that are genuinely useful to know.
Alcohol is a depressant that disrupts sleep and mood. Even moderate drinking can worsen depression, fragment sleep (a key trigger), interact with your medicines, and lower the threshold for an episode. Heavy use is a frequent driver of relapse.
Cannabis is not a neutral “calming” herb in bipolar disorder. It is associated with earlier onset, more episodes, worse symptoms, and higher relapse and psychosis risk. Many people use it to self-soothe and find it quietly destabilizes them over time.
Stimulants and other drugs can directly trigger highs. Cocaine, methamphetamine, and even high-dose caffeine can mimic or set off mania, and stimulant misuse is especially risky.
It complicates the picture. Substances can imitate both highs and lows, making diagnosis and treatment harder, and they interact with mood medicines in unpredictable ways.
What helps: The best outcomes come from treating substance use and bipolar disorder together — not “getting sober first, then dealing with mood,” and not the reverse. Be honest with your team; they need accurate information to help you, and disclosure leads to better care, not judgment. If cutting down is hard, that’s common and treatable — ask about integrated dual-diagnosis programs, counseling, and peer support. Reducing alcohol and drugs is often one of the single most effective things a person can do to stay well.
A mood chart turns vague impressions into a pattern you and your clinician can act on. It does not need to be fancy — consistency matters more than detail. Once a day, ideally at the same time, jot down:
Mood on a simple scale (for example −3 deeply depressed, 0 balanced, +3 clearly “high”/elevated).
Hours slept the night before — sleep is one of the most useful early signals; a sudden drop in sleep need can precede mania.
Medicines taken (a quick yes/no helps you and your team see adherence honestly).
Notable events or stresses, alcohol or substance use, and for those who menstruate, cycle day (mood can shift with the cycle).
Optional: anxiety, irritability, or any early-warning sign from your personal list.
Review it before appointments and bring it with you — a month of dots often shows things memory alone misses, such as a slow slide into depression or a few short nights before an episode. Many free apps do this, but paper works just as well. The goal is to catch change early, when small adjustments are most effective.
Know your early-warning signs
Most people have a personal “signature” that an episode is starting — and it is often visible before the full episode. Learning yours, and writing them down with the people who know you, buys precious time to act.
Early signs of a high (mania/hypomania)
Early signs of a low (depression)
Needing less sleep but feeling fine; staying up late with energy
Withdrawing from people; canceling plans
Thoughts and speech speeding up; jumping between ideas
Loss of interest, pleasure, or motivation
New big plans, spending, or risk-taking; irritability
Hopelessness; harsh self-criticism
Feeling unusually confident, important, or “wired”
Sleeping or eating much more or much less; struggling to function
Make a written crisis and safety plan
A crisis plan written while you are well helps everyone act fast when warning signs appear. A good plan names: your early-warning signs; what has helped before; who to call (clinician, trusted people); your medicines and doses; what you want others to do (and not do) during an episode; and crisis numbers including 988. Share it with people you trust.
Catching an episode early — in the days when warning signs first appear, before it is in full swing — is where you have the most influence. Here is a concrete playbook to discuss and personalize with your clinician ahead of time.
If a high (mania/hypomania) seems to be starting:
Protect sleep immediately. A drop in sleep both signals and fuels a high. Prioritize getting a full night; your clinician may have a plan for a short-term sleep aid for exactly this moment.
Contact your clinician early — don’t wait to see if it passes. Early adjustment is far easier than treating a full episode.
Put your financial and decision safeguards into action (see the section on protecting finances during a high), and postpone any big, irreversible decisions.
Reduce stimulation: dial back caffeine, alcohol, late nights, and over-scheduling; keep your days calmer and more structured.
Lean on your agreed plan with a trusted person — this is the moment it was made for, even if part of you feels fine.
If a low (depression) seems to be starting:
Tell your clinician — the depressive side has specific treatments, and catching a slide early can blunt it.
Keep your routine and your medicine going even when motivation drops; small consistency matters most here.
Stay connected — withdrawing deepens depression. Even minimal contact with supportive people helps.
Watch for danger signs. If thoughts of suicide appear, treat it as urgent: tell someone, remove access to means, and call or text 988.
For any episode: keep taking your medicine (don’t stop on your own), use your mood chart to confirm what you’re seeing, and activate your support network. The goal isn’t to handle it alone — it’s to act early and let your plan and your team do their work.
About suicide risk — said plainly and hopefully. Bipolar disorder carries an elevated risk of suicide, especially during depression and mixed states. This is exactly why getting and staying in treatment matters — and why lithium, which uniquely lowers suicide risk, is so valued. If you are having thoughts of suicide, you are not alone and help works: call or text 988 (Suicide and Crisis Lifeline) any time, or go to an emergency room. Reducing access to means (for example, having someone hold firearms or limit medication supply during high-risk periods) saves lives. Tell someone. These periods pass with help.
Feeling well on medicine doesn’t mean you no longer need it — it usually means it’s working. Bipolar disorder is a relapsing condition; the medicine is holding the relapse back. Stopping when you feel good is the most common cause of a return of episodes, and stopping suddenly (especially lithium) can itself trigger one. If you want to come off a medicine — because of side effects, pregnancy plans, or anything else — that is a reasonable conversation to have, but it should be planned and tapered with your prescriber, not done on your own.
What talk therapy would help me most, and how do I access it?
How do I figure out my personal early-warning signs?
Can we make a written crisis and safety plan together?
What should my support people do when they notice warning signs?
How strict do I need to be about sleep, and what about shift work or travel?
What should I do about alcohol?
What exactly should I do in a crisis, and who do I call first?
Caregiver note. Two of the most valuable things a caregiver can do are (1) help protect a steady sleep–wake routine and reduced alcohol use, and (2) help keep the crisis plan and medication/lab schedule on track without policing. Attend a psychoeducation or family-focused session together if you can — understanding the illness as a team reduces conflict and relapses. And take care of your own wellbeing; supporting someone through episodes is demanding, and your steadiness depends on it.
Coming out of a manic or depressive episode is its own phase, and going too fast is a common setback. Recovery is not a switch that flips when the acute episode ends — energy, concentration, confidence, and sleep often take weeks longer to fully return. Some gentle principles help:
Pace the re-entry. Rather than returning to full speed at once, ramp up gradually — reduced hours or lighter duties at first, where possible. A graded return protects against the stress and sleep disruption that can trigger a relapse.
Rebuild routine first. Steady sleep, meals, and daily structure are the foundation that everything else rests on. Get these solid before taking on heavy demands.
Be patient with thinking and memory. After an episode (and sometimes from medication), concentration and memory can lag for a while. This usually improves; meanwhile, lists, reminders, and lowered self-expectations help.
Make amends at a measured pace. If a manic episode strained relationships or finances, addressing them matters — but do it steadily, with support, not in an anxious rush that becomes its own stressor.
Know your rights at work and school. In many places, bipolar disorder qualifies for reasonable accommodations (adjusted schedules, a graded return, protected break times). You choose how much to disclose; a clinician’s letter can support accommodations without revealing details you’d rather keep private.
Watch for the post-episode dip. A let-down or low mood after a high is common; keep up your medicine, your routine, and contact with your team during this vulnerable window.
Recovery is real and usually fuller than people fear in the thick of an episode — but it rewards patience. Treat the weeks after an episode as part of treatment, not as “back to normal” already.
Hospital care is sometimes the safest option, and it is not a failure — it is a tool for getting through a dangerous stretch quickly and safely. Understanding when and how it happens reduces the fear around it.
When hospital care may be needed:
Thoughts of suicide with intent or a plan, or an inability to stay safe.
Severe mania — especially with psychosis, dangerous behavior, or an inability to sleep, eat, or function safely.
A mixed state with high distress and agitation.
A situation where symptoms can’t be managed safely at home and need close, around-the-clock support to stabilize.
What to expect: Most psychiatric admissions are short and focused on safety and stabilization — adjusting medication in a protected setting, restoring sleep, and putting a follow-up plan in place. Care is usually voluntary; involuntary admission exists only for situations of serious danger and is governed by legal protections that vary by location. Bringing (or having someone bring) your medication list and crisis plan helps the team treat you safely and according to your wishes.
Planning ahead helps. Including your preferences in a written crisis plan — which hospital, who to contact, what has helped before, and what you want others to do — means that even in a crisis, your own voice guides the care. Some people also explore formal tools like a psychiatric advance directive. Knowing the option exists, and having a plan for it, makes a hospital stay far less frightening if it is ever needed.
A fuller guide for caregivers, partners, and family
Caregivers are not bystanders — consistent, informed support measurably improves outcomes. Here is a more complete picture of what helps.
You may spot a shift before the person does. Early signs of a high: needing less sleep but seeming fine, talking faster, new big plans or spending, increased irritability, risk-taking, or grandiosity. Early signs of a low: withdrawing, canceling plans, hopelessness, loss of function, sleeping or eating very differently. The most useful thing is to agree in advance, while the person is well, on what you’ll do if you notice these — for example, “If I stop sleeping for two nights, please remind me to call my doctor.” Acting on early signs is far easier than acting in a full episode.
During mania or hypomania, a person often genuinely cannot see that anything is wrong — they may feel better than ever. This loss of insight is a symptom of the illness, not stubbornness, denial, or a personal attack on you. Arguing about whether they’re “sick” rarely helps and often escalates. What helps more: staying calm, focusing on safety, gently referencing the plan you made together when well, and involving the clinician early. You are not failing if you can’t talk someone out of a manic belief — that’s the nature of the symptom.
Help make consistency easy rather than enforced: shared reminders, a visible pill organizer, linking medicine to an existing daily habit. Help track lab appointments — especially lithium levels and kidney and thyroid tests — and keep a note of the dates. Learn the lithium-toxicity warning signs (persistent vomiting or diarrhea, coarse tremor, unsteadiness, slurred speech, confusion) and the dehydration triggers that raise risk (stomach bugs, hot weather, intense exercise, fasting). If toxicity signs appear, treat it as urgent: contact the clinician or seek care, and keep the person hydrated unless told otherwise.
Seek urgent or emergency help for: any suicidal thoughts or plans; inability to stay safe; psychosis (false beliefs, hearing/seeing things); severe agitation; or an inability to function safely (not eating/drinking, dangerous behavior). For a mental-health crisis, call or text 988; for immediate physical danger, call emergency services. Keep crisis numbers and the person’s medication list somewhere easy to grab.
Support the basics that stabilize mood: regular sleep, reduced alcohol and recreational drugs, and a predictable daily rhythm. If the person can become pregnant, support early reproductive and pregnancy planning with their team — medicine choices matter a great deal and are best worked out before conception, not after. Finally, care for yourself: caregiver burnout is real. Use your own support network, consider a support group (NAMI Family-to-Family, DBSA), set sustainable limits, and remember that your steadiness is part of what helps — you can’t pour from an empty cup.
Stigma, work, and relationships — living a full life
A diagnosis can feel like it changes how you see yourself, but bipolar disorder does not define you or limit what you can do. Many people work in demanding careers, raise families, and pursue ambitious goals with bipolar disorder — often with reasonable accommodations like protecting sleep, managing schedules, and staying in treatment. You are not obligated to disclose your diagnosis to employers or acquaintances; that’s your choice. Stigma is real, but it is fading, and it is not a reason to avoid getting help. The combination of effective treatment, steady routines, supportive relationships, and self-knowledge is what turns bipolar disorder from a series of crises into a manageable, long-term condition — one chapter of a full life, not the whole story.
One of the most painful aspects of mania and hypomania is that the decisions made during a high — impulsive spending, risky ventures, sudden relationship choices — can have lasting consequences that the person deeply regrets once well. Because insight often disappears during a high, the most effective protections are ones you set up in advance, while you are stable.
Practical safeguards many people find helpful:
Financial guardrails. Consider arrangements you control while well: a trusted person who can help monitor or temporarily hold access to large accounts or credit cards during a high; lowering credit limits; a “waiting period” rule for big purchases; or keeping a separate, hard-to-access savings account. Some people set these up with a partner or family member as part of their crisis plan.
Agree on a plan with someone you trust. While well, decide together what they should do if they notice warning signs — for example, “If I start making big plans or spending, remind me of this conversation and help me call my clinician.” Having agreed to it in advance makes it feel like support, not control.
Protect major decisions. Big, irreversible choices (quitting a job, large investments, major relationship decisions) are best postponed until you and your clinician agree you’re stable. A personal rule to “sleep on it for a week and check with one trusted person” can prevent a great deal of harm.
Plan for digital impulsivity. Online shopping, gambling, and social media can fuel impulsive behavior during a high. Some people remove saved payment details, use app limits, or ask someone to help manage access during episodes.
Repair, don’t just regret. If a past episode caused financial or relationship damage, that is the illness, not a moral failing. Many consequences can be addressed over time — through honest conversations, financial counseling, and rebuilding trust — and putting safeguards in place now reduces the chance of it recurring.
These measures are not about giving up your independence — they are about you, while well, protecting your future self from a symptom of the illness. Setting them up is a sign of strength and self-knowledge, not weakness.
Pregnancy, Youth & Special Situations
Pregnancy and the postpartum period
Bipolar disorder and pregnancy can be managed well — but it takes planning, ideally before conception. Two facts shape everything: first, the time around childbirth is one of the highest-risk periods for relapse, including the psychiatric emergency of postpartum psychosis; second, the medicines differ greatly in their safety during pregnancy, so the choice is individualized.
Medicine
Pregnancy considerations (discuss with your team)
Valproate
Generally avoided in people who can become pregnant — it can cause serious birth defects (including neural-tube defects) and harm brain development. Regulators in the UK, EU, and elsewhere have placed strong restrictions on its use.
Lithium
Carries a small increased risk of a heart defect; for many people the benefit of staying well outweighs this, with monitoring. Levels need closer tracking in pregnancy and around delivery.
Lamotrigine
Generally considered one of the more reassuring options in pregnancy for many people; dose may need adjusting as pregnancy changes how the body handles it.
Antipsychotics
Several are used in pregnancy when needed; data are reassuring for some agents. Choice is individualized.
Don’t stop on your own. Stopping medicine abruptly because of a positive pregnancy test is a common and dangerous mistake — relapse risk is high and the postpartum period is especially fragile. If you are pregnant or planning to be, talk to your team urgently to make a plan; do not stop medicine without that conversation.
Breastfeeding is possible with some medicines and not advised with others; this, too, is an individualized discussion. The overarching message: with preconception counseling and a coordinated plan between psychiatry and obstetrics, most people with bipolar disorder have healthy pregnancies and babies.
Children and adolescents
Bipolar disorder can begin in the teens (and, less commonly, earlier). Diagnosis in young people is careful work, because normal adolescence and other conditions (like ADHD) can overlap, and because a single low mood is not enough — clinicians look for clear episodes of elevated, expansive, or irritable mood with reduced need for sleep and out-of-character behavior. Some medicines are specifically approved for youth; treatment should be guided by a child and adolescent psychiatrist, and family involvement (including family-focused therapy) is especially valuable. Watch sleep, school functioning, and any new risk-taking closely, and keep antidepressants under careful review because of switch risk. With the right plan, many young people stabilize and stay in school, sports, and friendships — early, steady treatment protects the developing path ahead.
Older adults
In older adults, doses are often lower, drug interactions and other medical conditions matter more, and lithium needs especially careful kidney and thyroid monitoring because the kidneys clear it more slowly and dehydration (from illness, heat, or diuretics) can push levels up quickly. New manic symptoms appearing for the first time later in life should prompt a check for medical or neurological causes and medication effects. Antipsychotics are used cautiously, and the dementia-related-psychosis warning is kept in mind for those with dementia. The principles are the same; the margins are tighter, so monitoring and a clear medication list shared across all prescribers matter even more.
Relationships, family life, and parenting
Bipolar disorder is managed within relationships, not in isolation, and a few honest considerations help. Partners and close family do best when they understand the illness as a medical condition with episodes — not as unpredictability to be taken personally — and when they are brought in, while you are well, to a shared plan for recognizing early warning signs and what to do about them. Couples or family education (including formal family-focused therapy) measurably reduces conflict and relapse, and reduces the loneliness that the illness can create on both sides. Honest, low-pressure conversation about money safeguards, sleep routines, and crisis steps turns a partner from a worried bystander into an informed ally.
For parents, two reassurances and one practical point matter. First, having bipolar disorder does not mean you cannot be a good parent; with treatment and support, many people with bipolar disorder raise children well. Second, because the condition has a genetic component, it is worth being calmly alert to early signs in children — not anxiously watching, but knowing that early help is available if ever needed. The practical point: protect your own treatment and sleep, because the demands of parenting (especially the sleep disruption of a new baby) are real triggers — which is exactly why the pregnancy and postpartum planning described above, and a strong support system afterward, are so important. Building a circle of support — partner, family, clinicians, and peers — protects both you and your family.
Common co-occurring conditions
Anxiety disorders, substance-use disorders, and ADHD frequently occur alongside bipolar disorder, and each affects treatment. People with bipolar disorder also have higher rates of heart disease and other physical conditions and, on average, a shortened life expectancy — much of it from preventable physical illness. That makes routine physical-health care — blood pressure, weight, blood sugar, cholesterol, smoking, exercise — an essential part of bipolar care, not an afterthought.
A few practical points if you live with these together: anxiety and bipolar disorder are best tackled by getting the mood treatment right first, adding talk therapy, and being cautious with ordinary antidepressants and with sedatives. Alcohol and other substances are worth treating at the same time as your mood — not “once you're stable” — because they are one of the most common reasons treatment seems to stop working. If you also have ADHD, it's usually best to stabilize mood before treating it, and to use stimulant medicines carefully and under close watch, since they can sometimes tip mood upward. And because heart and metabolic health drive much of the long-term risk, treating high blood pressure, weight, blood sugar, and smoking is genuinely part of treating bipolar disorder — ask your team to keep an eye on these with you.
Anxiety is very common with bipolar disorder and can worsen the course. It’s treated thoughtfully — some anxiety treatments overlap with bipolar treatment, and some (like certain antidepressants) need the same caution as in bipolar depression. Therapy (CBT) is especially useful here.
Substance use — alcohol, cannabis, stimulants — is also common and is one of the biggest reasons treatment stops working. It can mimic or trigger episodes, interact with medicines, and raise risk. Treating substance use and bipolar disorder together (not one “first”) gives the best results; tell your team honestly so they can help rather than judge.
ADHD can co-occur and shares some features (distractibility, restlessness). Stimulant treatment for ADHD is sometimes used carefully after mood is stabilized, because stimulants can destabilize mood if used while a mood episode is active or untreated.
The reduced life expectancy associated with bipolar disorder is driven largely by preventable physical illness — especially heart disease — not by the mood disorder itself. That’s actually hopeful, because these risks are modifiable. Practical priorities: keep up with weight, blood pressure, blood sugar, and cholesterol checks (especially on antipsychotics); don’t smoke (and get help to quit if you do); stay physically active; and treat sleep apnea and other conditions. Ask your team to coordinate your mental and physical health rather than treating them in separate silos.
If pregnancy is possible in your future, the best time to plan is before conceiving. A preconception conversation can cover: which of your medicines are safest in pregnancy and whether to switch in advance; the risks of stopping medicine versus continuing; how to monitor more closely during pregnancy (lithium levels, for example, shift as the body changes); the elevated relapse risk after delivery and a plan to protect that period; and whether you can breastfeed on your medicine. The aim is a coordinated plan between psychiatry and obstetrics, made calmly ahead of time rather than urgently after a positive test.
If I might become pregnant, which of my medicines are safe, and what should I plan before conceiving?
What is the plan to protect me in the postpartum period, when relapse risk is highest?
Can I breastfeed on my medicine?
(For a young person) Is this medicine approved for someone my age, and should we add family therapy?
(For an older adult) How should my dose and monitoring change with age and my other medicines?
How are we taking care of my heart, weight, and blood sugar over the long term?
How should we handle my co-occurring anxiety / substance use / ADHD alongside bipolar treatment?
class="content-section" data-stage="trials">
Clinical Trials & Research
Research keeps expanding the toolkit. Joining a clinical trial is a personal choice — it can offer access to new approaches and contributes to knowledge that helps everyone — and it is reasonable to ask about trials anywhere in the world. Trials are international, and progress in bipolar disorder is a global effort.
How to search. The U.S. registry ClinicalTrials.gov lists trials worldwide; you can search “bipolar disorder” plus your city or interest. The World Health Organization’s International Clinical Trials Registry Platform (trialsearch.who.int) aggregates national registries. Your psychiatrist or a university medical center (such as the University of Utah’s Huntsman Mental Health Institute) can point you to studies you may qualify for. Never stop your current treatment to join a trial without your clinician’s guidance.
Areas of active research
Newer medicines for bipolar depression — the hardest part to treat — including drugs acting on novel brain targets.
Better long-acting options to make staying well easier for people who struggle with daily pills.
Brain-stimulation treatments — beyond ECT for severe illness, approaches like transcranial magnetic stimulation are being studied for bipolar depression; their role is still being defined, and they are used carefully because of switch risk.
Chronotherapy and sleep-based treatments — carefully supervised light therapy, dark therapy, and sleep-timing strategies as add-ons that work with the body’s daily rhythms.
Personalized treatment and biomarkers — using genetics and other markers to predict who will respond to lithium and other treatments, to choose the right medicine sooner.
Digital tools — smartphone-based mood tracking and early-warning detection to catch episodes earlier, always as a complement to (not a replacement for) clinical care.
These are real studies listed on ClinicalTrials.gov, shown to illustrate the kinds of research underway. Availability and recruiting status change — check the registry for current details before acting.
Lithium for Prevention of Cognitive Declining in Mood Illnesses (NCT06662526) — studying whether low-dose lithium can protect thinking and memory in people with mood disorders.
Effect of Regulated Add-on Sodium Chloride Intake on Stabilization of Serum Lithium (NCT04222816) — a study of how steady salt intake affects lithium levels and toxicity risk.
Collaborative Lithium Trials (CoLT) (NCT00442039 and NCT01166425) — the studies that supported lithium’s use and labeling in children and adolescents.
Navacaprant for bipolar II depression (NCT06429722) — a completed study of an experimental once-daily pill that works through a brand-new target in the brain (a “kappa opioid receptor”), tested for the depression side of bipolar II. It is investigational — not approved — and is an example of researchers looking beyond the usual mechanisms to tackle bipolar depression, the hardest part to treat.
Are there clinical trials I might qualify for, here or at a nearby academic center?
What would joining a trial involve, and could I keep my current treatment?
Are any of the emerging approaches (new medicines, brain stimulation, light/dark therapy, digital tools) appropriate for me now?
How do I tell promising research apart from unproven claims I see online?
Failed & De-adopted Approaches (What Has Not Worked)
Being honest about what doesn’t work protects you from wasted time, money, and risk. You will encounter many of these claims online.
Antidepressants alone for bipolar depression. Not just ineffective in many cases — potentially harmful, because they can trigger mania, mixed states, or faster cycling when used without a mood stabilizer. This is the single most important “de-adopted” practice.
Some anticonvulsants that didn’t pan out for mood. In careful testing, gabapentin and topiramate did not work as treatments for acute mania, despite being anticonvulsants like valproate. (Topiramate is sometimes used for other reasons, such as weight, but not as a mood stabilizer.)
Stopping medicine once you feel well. Understandable, but the most common cause of relapse; abrupt lithium discontinuation can itself trigger an episode.
“Natural cure” and supplement claims that replace treatment. No supplement has been shown to control bipolar disorder on its own. Some interact with medicines. Anything taken should be disclosed to your prescriber, and nothing should replace standard care.
Treating it as a willpower or lifestyle problem. Routines and skills genuinely help, but bipolar disorder is a medical condition; diet and discipline alone do not control it.
A useful filter. Be cautious with anything that promises a cure, tells you to stop your medicine, charges a lot for a “protocol,” or relies on testimonials instead of trials. Bring such claims to your clinician — a good one will discuss them with you openly.
class="content-section" data-stage="centers">
Specialty Centers & Where to Get Help
Phone numbers and programs change — confirm details before you go. If you are in crisis right now, call or text 988.
Mountain West & Utah
University of Utah Huntsman Mental Health Institute (HMHI), Salt Lake City — comprehensive psychiatric care including specialized mood-disorder treatment, inpatient and outpatient services, ECT and neuromodulation, perinatal psychiatry, and clinical trials, with 24/7 crisis services. Main scheduling and information: 801-583-2500. HMHI also operates the receiving center and mobile crisis outreach.
Utah statewide crisis system / 988 — call or text 988 (Suicide and Crisis Lifeline) for 24/7 help; Utah’s system includes the HMHI receiving center and mobile crisis teams across the state.
Intermountain Health behavioral health services — psychiatry and counseling across the Wasatch Front and Utah, including behavioral health integrated into primary care.
NAMI Utah (namiut.org) and the Depression and Bipolar Support Alliance (DBSA) — peer support groups, education, and family resources.
US National centers of excellence
Many academic medical centers run specialized mood-disorder or bipolar programs (for example, within departments of psychiatry at major universities). Ask your psychiatrist for a referral to a mood-disorders specialty clinic if your illness is hard to control, if pregnancy is being planned, or if you want a second opinion. National organizations below can help you find specialists.
Veterans
George E. Wahlen Department of Veterans Affairs Medical Center (Salt Lake City) — mental health services including medication management and psychotherapy for bipolar disorder. The VA also runs the Veterans Crisis Line: dial 988 then press 1, or text 838255.
Ask about service connection for mental-health conditions and about VA specialty mental-health and ECT services.
Canada
Care is delivered through provincial health systems; the CANMAT (Canadian Network for Mood and Anxiety Treatments) guidelines are widely used. Drug coverage varies by province and plan, so ask about formulary coverage for newer agents. Talk Suicide Canada: 1-833-456-4566 (and 988 is now also active in Canada).
International
Specialized mood-disorder centers exist worldwide, often within university hospitals. The core medicines (lithium, valproate, lamotrigine, second-generation antipsychotics) are used globally, though access, monitoring, and which agents are first-choice differ by country. The WHO’s mental-health resources and national psychiatric societies are good starting points.
Caregiver note. Keep a one-page sheet with the person’s diagnosis, current medicines and doses, prescriber’s contact, and crisis numbers (including 988). In an emergency, having this ready saves critical time and helps clinicians treat safely.
International Access & Regulatory Landscape
The same illness is treated with broadly the same medicines worldwide, but availability, rules, and first-choice rankings differ. A quick orientation:
Therapy
US (FDA)
Europe / UK
Notes elsewhere
Lithium
Approved; foundational
Approved; NICE/UK and others rank it highly, often first-line for maintenance
Used globally; the degree of emphasis on lithium vs. antipsychotics varies by guideline
Valproate
Approved (with boxed warnings)
Approved but under strong pregnancy-prevention restrictions (UK MHRA, EU EMA)
Restrictions tightening internationally for people who can become pregnant
Lamotrigine
Approved for maintenance
Approved
Widely available; depression-prevention role recognized broadly
Quetiapine, aripiprazole, olanzapine, risperidone
Approved (various bipolar indications)
Approved
Widely available globally
Lurasidone
Approved for bipolar I depression (adults and ages 10–17)
Approved (availability varies by country)
Approval and access vary; check locally
Cariprazine
Approved for bipolar I depression, mania, and mixed
Approved (marketed in EU; some bipolar indications vary)
Access varies by market
Lumateperone
Approved for bipolar I and II depression
Availability varies; not universally approved
Newer agent; access expanding but uneven
Once-monthly risperidone injection (UZEDY)
Approved Oct 2025 for bipolar I maintenance (alone or with lithium/valproate)
Not a bipolar approval in EU/UK at US launch; check locally
Newly available in the US; access elsewhere will follow over time
Milsaperidone (Bysanti)
Approved Feb 2026 for manic/mixed episodes of bipolar I
US-first; not yet approved in EU/UK
Very new; international availability will lag
Honest gaps. Access to lithium blood-level monitoring, to the newer antipsychotics, and to structured psychotherapies differs greatly between health systems and even between clinics in the same country. Cost and insurance coverage are real barriers in many places, and stigma remains a barrier to seeking care worldwide. If a recommended treatment isn’t accessible to you, tell your clinician — there is almost always an effective alternative, and lithium in particular is inexpensive and available nearly everywhere.
Valproate, globally. Because valproate can seriously harm a developing baby, many regulators (EU/EMA, UK/MHRA, and others) have introduced strong pregnancy-prevention programs and restrictions on its use in people who can become pregnant — and, more recently, precautions for men around the time of conception. If you are on valproate and could become or father a child, ask your clinician about current rules and safer alternatives.
Glossary
Acute phase — treating an active episode (mania or depression) right now.
Bipolar I / II — bipolar I requires a full manic episode; bipolar II requires hypomania plus major depression and never full mania.
Cyclothymia — chronic, milder mood instability over two or more years that doesn’t meet full episode criteria.
Hypomania — a milder, shorter high that doesn’t cause major impairment, psychosis, or hospitalization.
Mania — a sustained high with major impairment, psychosis, or need for hospital care.
Maintenance phase — ongoing treatment to stay well and prevent the next episode.
Mixed features — high and low symptoms occurring together.
Mood stabilizer — lithium, valproate, lamotrigine, or carbamazepine.
Predominant polarity — whether you tend to relapse more into depression or into mania; helps choose a maintenance medicine.
Rapid cycling — four or more mood episodes in a year.
Second-generation (atypical) antipsychotic — medicines like quetiapine, lurasidone, cariprazine, and lumateperone, used in bipolar disorder as mood medicines.
Switch — flipping from depression into mania/hypomania, sometimes triggered by an antidepressant.
Therapeutic window — the range where a medicine (like lithium) works without being toxic.
Titration — gradually increasing a dose (lamotrigine must be titrated slowly).
Toxicity — harmful effects from too much of a medicine (lithium toxicity is a key example).
Key References & Sources
This guide draws on major clinical guidelines, regulatory information, and peer-reviewed studies. It is educational and does not replace personalized medical advice.
CANMAT and ISBD 2018 guidelines for the management of bipolar disorder (and CANMAT updates).
American Psychiatric Association (APA) practice guideline for bipolar disorder.
NICE clinical guideline CG185 (Bipolar disorder: assessment and management), UK.
British Association for Psychopharmacology (BAP) bipolar guidelines.
RANZCP mood-disorders clinical practice guidelines (Australia/New Zealand).
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines.
FDA labels for lithium, valproate, lamotrigine, carbamazepine, and the second-generation antipsychotics approved in bipolar disorder.
UK MHRA and EU EMA valproate pregnancy-prevention measures.
Cipriani A, et al. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ 2013 (PMID 23814104).
Cipriani A, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet 2011 (PMID 21851976).
Miura T, et al. Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a network meta-analysis. Lancet Psychiatry 2014 (PMID 26360999).
Calabrese JR, et al. Lamotrigine and lithium maintenance in recently depressed bipolar I patients. J Clin Psychiatry 2003 (PMID 14628976).
Bowden CL, et al. Lamotrigine and lithium maintenance in recently manic/hypomanic bipolar I patients. Arch Gen Psychiatry 2003 (PMID 12695317).
Patient and crisis resources: 988 Suicide and Crisis Lifeline; Depression and Bipolar Support Alliance (dbsa.org); International Bipolar Foundation (ibpf.org); ClinicalTrials.gov.
Final disclaimer. This guide is for education only and reflects evidence available as of June 2026; medical knowledge and approvals evolve. It does not establish a doctor–patient relationship and is not a substitute for individualized advice from your own qualified clinicians. Never start, stop, or change a medicine based on this guide alone. If you are in crisis, call or text 988.
⚠️ Safety Warnings & Critical Drug Risks
Lithium — Narrow Therapeutic Index; Toxicity From Dehydration
Lithium toxicity can occur even at “therapeutic” levels: signs of lithium toxicity — coarse tremor, nausea, vomiting, diarrhea, confusion, ataxia (unsteady gait), slurred speech, drowsiness — go to the emergency department; lithium toxicity is a medical emergency and can cause permanent neurological damage or death
Dehydration and sodium depletion rapidly raise lithium levels: any illness with vomiting, diarrhea, or fever; hot weather with heavy sweating; low-sodium diet (lithium is retained when sodium is low); diuretics (thiazides/loop diuretics markedly increase lithium levels — inform all prescribers); NSAIDs (ibuprofen/naproxen — raise lithium levels significantly — use acetaminophen instead or check with prescriber); ACE inhibitors and ARBs — hold lithium and seek physician guidance in these situations
Regular blood level monitoring is mandatory: typically every 3-6 months for stable patients; renal function (creatinine) and thyroid function (TSH) also require regular monitoring — lithium causes hypothyroidism in up to 40% of long-term users; report weight gain, fatigue, or cold intolerance
Never stop lithium abruptly without psychiatric guidance — rapid discontinuation is associated with severe manic rebound and increased suicidal risk; taper over weeks to months under supervision
Valproate — FDA Boxed Warning: Teratogenicity (Neural Tube Defects)
Boxed Warning — major congenital malformations: valproate (Depakote) causes serious birth defects including neural tube defects (spina bifida), heart defects, craniofacial abnormalities, and cognitive impairment (IQ reduction) in exposed children; folic acid supplementation does NOT adequately protect against these effects — valproate should not be used in women of childbearing potential unless alternatives have been tried and failed; REMS enrollment is required
Hepatotoxicity Boxed Warning: particularly in children under 2 and patients taking multiple antiepileptics; report right upper abdominal pain/jaundice/fatigue/loss of appetite; LFT monitoring required; do not ignore warning signs
Pancreatitis Boxed Warning: report severe abdominal pain; can be fatal; hold valproate if pancreatitis is suspected
Valproate raises lamotrigine blood levels approximately 2-fold — lamotrigine dose must be reduced if valproate is added; this drug interaction can cause lamotrigine toxicity (dizziness, diplopia, rash)
Lamotrigine — life-threatening rash: Stevens-Johnson Syndrome (SJS/TEN) can be fatal; any new rash during lamotrigine treatment — stop the drug immediately and seek medical care; risk is higher with rapid dose escalation — titration must be very slow (several weeks); never restart lamotrigine after a rash attributed to it
Antipsychotics (olanzapine/quetiapine/risperidone): metabolic monitoring required — weight, fasting glucose, and lipids at baseline and at least annually; significant weight gain and risk of type 2 diabetes; QTc prolongation (especially quetiapine, ziprasidone); neuroleptic malignant syndrome (NMS — rare but life-threatening: hyperthermia, severe muscle rigidity, altered consciousness — emergency evaluation)
Antidepressants in bipolar: antidepressants alone (without mood stabilizer) can trigger manic switch or rapid cycling in bipolar disorder — never start antidepressants without concurrent mood stabilizer coverage; discuss carefully with psychiatrist
Suicidality risk: FDA safety communication on antiepileptic drugs (including lithium and anticonvulsant mood stabilizers) — suicidal thoughts can occur during mood episodes; emergency contact plan and crisis line number should be established with your care team